Page No,Table Title,Row Headers,Subsections,Source,Quality Score,Backend
1,Securities registered pursuant to Section 12(b) of the Act:,"$,; $,; $,; $,; $,; $,; $,; $,; $,; $,",,10q0325.pdf,27.096662030598054,docling
1,Securities registered pursuant to Section 12(b) of the Act:,"$,; $,; $,; Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026 of Morgan Stanley Finance LLC (and Registrant's guarantee with respect thereto); Global Medium-Term Notes, Series A, Floating Rate Notes Due 2029 of Morgan Stanley Finance LLC (and Registrant's guarantee with respect thereto)",,10q0325.pdf,27.096662030598054,docling
7,Selected Financial Information and Other Statistical Data,"$ in millions, except per share data; [Consolidated results]; Net revenues; Earnings applicable to Morgan Stanley common shareholders; Earnings per diluted common share; [Consolidated financial measures]; Expense efficiency ratio; ROE; ROTCE 2,; Pre-tax margin",Consolidated results; Consolidated financial measures,10q0325.pdf,27.096662030598054,docling
7,Selected Financial Information and Other Statistical Data,"ROE; ROTCE 2,; Pre-tax margin; Effective tax rate; [Pre-tax margin by segment]; Institutional Securities; Wealth Management; Investment Management",Pre-tax margin by segment,10q0325.pdf,27.096662030598054,docling
7,Selected Financial Information and Other Statistical Data,Average liquidity months ended; Loans; **Total assets**; Deposits; Borrowings; Common equity; Tangible common equity; Common shares outstanding; Book value per common share; Tangible book value per common,,10q0325.pdf,27.096662030598054,docling
7,Selected Financial Information and Other Statistical Data,Common shares outstanding; Book value per common share; Tangible book value per common; Worldwide employees (in thousands); Client assets 8 (in billions); [Capital Ratios]; Common Equity Tier 1 capital- Standardized; Tier; Common Equity Tier 1 capital-Advanced; Tier 1 capital-Advanced,Capital Ratios,10q0325.pdf,27.096662030598054,docling
7,Selected Financial Information and Other Statistical Data,Tier; Common Equity Tier 1 capital-Advanced; Tier 1 capital-Advanced; Tier 1 leverage; SLR,,10q0325.pdf,27.096662030598054,docling
8,Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures,$ in millions; Net revenues; Adjustment for mark-to-market losses (gains) on DCP; Adjusted Net revenues-non-GAAP; Compensation expense; Adjustment for mark-to-market gains (losses) on DCP; Adjusted Compensation expense-non- GAAP; Wealth Management Net revenues; Adjustment for mark-to-market losses (gains) on DCP; Adjusted Wealth Management Net revenues-non-GAAP,,10q0325.pdf,27.096662030598054,docling
8,Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures,Wealth Management Net revenues; Adjustment for mark-to-market losses (gains) on DCP; Adjusted Wealth Management Net revenues-non-GAAP; Wealth Management Compensation expense; Adjustment for mark-to-market gains (losses) on DCP; Adjusted Wealth Management Compensation expense-non-GAAP,,10q0325.pdf,27.096662030598054,docling
8,Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures,[Tangible equity]; Common equity; Less: Goodwill and net intangible assets; Tangible common equity-non-GAAP,Tangible equity,10q0325.pdf,27.096662030598054,docling
9,Management's Discussion and Analysis,$ in millions; [Tangible equity]; Common equity; Less: Goodwill and net intangible assets; Tangible common equity-non-GAAP,Tangible equity,10q0325.pdf,27.096662030598054,docling
9,Non-GAAP Financial Measures by Business Segment,$ in billions; [Average common equity]; Institutional Securities; Wealth Management; Investment Management; [ROE]; Institutional Securities; Wealth Management; Investment Management; [Average tangible common equity],Average common equity; ROE; Average tangible common equity,10q0325.pdf,27.096662030598054,docling
9,Non-GAAP Financial Measures by Business Segment,Wealth Management; Investment Management; [Average tangible common equity]; Institutional Securities; Wealth Management; Investment Management; [ROTCE]; Institutional Securities; Wealth Management; Investment Management,Average tangible common equity; ROTCE,10q0325.pdf,27.096662030598054,docling
9,Non-GAAP Financial Measures by Business Segment,Institutional Securities; Wealth Management; Investment Management,,10q0325.pdf,27.096662030598054,docling
10,Income Statement Information,$ in millions; [Revenues]; Advisory; Equity; Fixed Income; **Total Underwriting**; **Total Investment Banking**; Equity; Fixed Income; Other,Revenues,10q0325.pdf,27.096662030598054,docling
10,Income Statement Information,Equity; Fixed Income; Other; Net revenues; Provision for credit losses; Compensation and benefits; Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes,,10q0325.pdf,27.096662030598054,docling
10,Income Statement Information,**Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes; Net income; Net income applicable to noncontrolling interests; Net income applicable to Morgan Stanley,,10q0325.pdf,27.096662030598054,docling
10,Investment Banking Volumes,"$ in billions; Completed mergers and acquisitions; Equity and equity- related offerings 2,; Fixed Income offerings 2,",,10q0325.pdf,27.096662030598054,docling
10,Equity and Fixed Income Net Revenues,$ in millions; Financing; Execution services; **Total Equity**; **Total Fixed Income**,,10q0325.pdf,27.096662030598054,docling
10,Equity and Fixed Income Net Revenues,Financing; Execution services; **Total Equity**; **Total Fixed Income**,,10q0325.pdf,27.096662030598054,docling
12,Income Statement Information,$ in millions; [Revenues]; Asset management; Transactional; Net interest; Other; Net revenues; Provision for credit losses; Compensation and benefits; Non-compensation expenses,Revenues,10q0325.pdf,27.096662030598054,docling
12,Income Statement Information,Provision for credit losses; Compensation and benefits; Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes; Net income applicable to Morgan Stanley,,10q0325.pdf,27.096662030598054,docling
12,Wealth Management Metrics,**Total client assets**; U.S. Bank Subsidiary loans; Margin and other lending; Deposits; [Annualized weighted average cost of deposits]; Period end; Period average for three months ended,Annualized weighted average cost of deposits,10q0325.pdf,27.096662030598054,docling
12,Wealth Management Metrics,Net new assets,,10q0325.pdf,27.096662030598054,docling
12,Advisor-Led Channel,Advisor-led client assets; Fee-based client assets; Fee-based client assets as a percentage of advisor-led client assets; Fee-based asset flows,,10q0325.pdf,27.096662030598054,docling
12,Self-Directed Channel,Self-directed client assets 1 (in billions); Self-directed households 2 (in millions); Daily average revenue trades ('DARTs') 3 (in thousands),,10q0325.pdf,27.096662030598054,docling
12,Workplace Channel,Stock plan unvested assets 2 (in billions); Stock plan participants 3 (in millions),,10q0325.pdf,27.096662030598054,docling
13,Fee-Based Client Assets Rollforwards,Separately managed; Unified managed; Advisor; Portfolio manager; **Subtotal**; Cash management; **Total fee-based client assets**,,10q0325.pdf,27.096662030598054,docling
13,Fee-Based Client Assets Rollforwards,Separately managed; Unified managed; Advisor; Portfolio manager; **Subtotal**; Cash management; **Total fee-based client assets**,,10q0325.pdf,27.096662030598054,docling
14,Average Fee Rates,Fee rate in bps; Separately managed; Unified managed; Advisor; Portfolio manager; **Subtotal**; Cash management; **Total fee-based client assets**,,10q0325.pdf,27.096662030598054,docling
15,Income Statement Information,$ in millions; [Revenues]; Asset management and related fees; Performance-based income and other; Net revenues; Compensation and benefits; Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes,Revenues,10q0325.pdf,27.096662030598054,docling
15,Income Statement Information,**Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes; Net income; Net income applicable to Morgan Stanley,,10q0325.pdf,27.096662030598054,docling
15,Assets Under Management or Supervision Rollforwards,Equity; Fixed Income; Alternatives and Solutions; Long-Term AUM; Liquidity and Overlay Services; **Total**; $ in billions; Equity; Fixed Income; Alternatives and Solutions,,10q0325.pdf,27.096662030598054,docling
15,Assets Under Management or Supervision Rollforwards,Equity; Fixed Income; Alternatives and Solutions; Long-Term AUM; Liquidity and Overlay Services; **Total**,,10q0325.pdf,27.096662030598054,docling
15,Average AUM,$ in billions; Equity; Fixed income; Alternatives and Solutions; **Long-termAUM subtotal**; Liquidity and Overlay Services; **Total AUM**,,10q0325.pdf,27.096662030598054,docling
16,Average Fee Rates,Fee rate in bps; Equity; Fixed income; Alternatives and Solutions; Long-termAUM; Liquidity and Overlay Services; **TotalAUM**,,10q0325.pdf,27.096662030598054,docling
17,U.S. Bank Subsidiaries' Supplemental Financial Information,[Investment securities:];   Available-for-sale at fair value;   Held-to-maturity; **Total Investment securities**; [Wealth Management loans]; Residential real estate; Securities-based lending and Other; **Total Wealth Management loans**; [Institutional Securities loans]; Corporate,Investment securities:; Wealth Management loans; Institutional Securities loans,10q0325.pdf,27.096662030598054,docling
17,U.S. Bank Subsidiaries' Supplemental Financial Information,**Total Wealth Management loans**; [Institutional Securities loans]; Corporate; Secured lending facilities; Commercial and Residential real estate; Securities-based lending and Other; **Total Institutional Securities loans**; **Total assets**; Deposits,Institutional Securities loans,10q0325.pdf,27.096662030598054,docling
18,Total Assets by Business Segment,$ in millions; [Assets]; Cash and cash equivalents; Trading assets at fair value; Investment securities; Securities purchased under agreements to resell; Securities borrowed; Customer and other receivables; Loans; Goodwill,Assets,10q0325.pdf,27.096662030598054,docling
18,Total Assets by Business Segment,Customer and other receivables; Loans; Goodwill; Intangible assets; Other assets; **Total assets**,,10q0325.pdf,27.096662030598054,docling
18,Total Assets by Business Segment,$ in millions; [Assets]; Cash and cash equivalents; Trading assets at fair value; Investment securities; Securities purchased under agreements to resell; Securities borrowed; Customer and other receivables; Loans; Goodwill,Assets,10q0325.pdf,27.096662030598054,docling
18,Total Assets by Business Segment,Customer and other receivables; Loans; Goodwill; Intangible assets; Other assets; **Total assets**,,10q0325.pdf,27.096662030598054,docling
18,Liquidity Resources by Type of Investment,$ in millions; Cash deposits with central banks; [Unencumbered HQLASecurities 1 :];   U.S. government obligations;   U.S. agency and agency mortgage- backed securities;   Non-U.S. sovereign obligations;   Other investment grade securities; **Total HQLA**; Cash deposits with banks (non-HQLA); **Total Liquidity Resources**,Unencumbered HQLASecurities 1 :,10q0325.pdf,27.096662030598054,docling
19,Liquidity Resources by Non-Bank and Bank Legal Entities,$ in millions; [Non-Bank legal entities]; [U.S.:];   Parent Company;   Non-Parent Company; **Total U.S.**; Non-U.S.; **Total Non-Bank legal entities**; [Bank legal entities];   U.S.,Non-Bank legal entities; U.S.:; Bank legal entities,10q0325.pdf,27.096662030598054,docling
19,Liquidity Resources by Non-Bank and Bank Legal Entities,**Total Non-Bank legal entities**; [Bank legal entities];   U.S.;   Non-U.S.; **Total Bank legal entities**; **Total Liquidity Resources**,Bank legal entities,10q0325.pdf,27.096662030598054,docling
19,Liquidity Coverage Ratio,$ in millions; [Eligible HQLA]; Cash deposits with central banks; Securities; **Total Eligible HQLA**; Net cash outflows; LCR,Eligible HQLA,10q0325.pdf,27.096662030598054,docling
19,Collateralized Financing Transactions,Securities purchased under agreements to resell and Securities borrowed; Securities sold under agreements to repurchase and Securities loaned; Securities received as collateral,,10q0325.pdf,27.096662030598054,docling
20,Management's Discussion and Analysis,$ in millions; Securities purchased under agreements to resell and Securities borrowed; Securities sold under agreements to repurchase and Securities loaned,,10q0325.pdf,27.096662030598054,docling
20,Deposits,[Savings and demand deposits:];   Brokerage sweep deposits;   Savings and other; **Total Savings and demand deposits**; Time deposits; **Total**,Savings and demand deposits:,10q0325.pdf,27.096662030598054,docling
20,Our deposits are primarily held in U.S. offices.,Original maturities of one year or less; Original maturities greater than one year 2025; 2026; 2027; 2028; 2029; Thereafter; **Total greater than one year**; **Total**; Maturities over next 12 months,,10q0325.pdf,27.096662030598054,docling
21,"Parent Company and U.S. Bank Subsidiaries Issuer Ratings at April 30,","DBRS, Inc.; Fitch Ratings, Inc.; Moody's Investors Service, Inc.; Rating and Investment Information, Inc.; S&P Global Ratings",,10q0325.pdf,27.096662030598054,docling
21,"Parent Company and U.S. Bank Subsidiaries Issuer Ratings at April 30,","Fitch Ratings, Inc.; Moody's Investors Service, Inc.; S&P Global Ratings",,10q0325.pdf,27.096662030598054,docling
21,"Parent Company and U.S. Bank Subsidiaries Issuer Ratings at April 30,","Fitch Ratings, Inc.; Moody's Investors Service, Inc.; S&P Global Ratings",,10q0325.pdf,27.096662030598054,docling
21,Common Stock Repurchases,"in millions, except for per share data; Number of shares; Average price per share; **Total**",,10q0325.pdf,27.096662030598054,docling
21,Common Stock Dividend Announcement,Amount per share; Date to be paid; Shareholders of record as of,,10q0325.pdf,27.096662030598054,docling
22,Risk-Based Regulatory Capital Ratio Requirements,[Capital buffers]; Capital conservation buffer; SCB; G-SIB capital surcharge; CCyB; Capital buffer requirement,Capital buffers,10q0325.pdf,27.096662030598054,docling
22,"The CCyB can be set up to 2.5%, but is currently set by the Federal Reserve at zero.",[Required ratios]; CET1 capital ratio; Tier 1 capital ratio; **Total capital ratio**,Required ratios,10q0325.pdf,27.096662030598054,docling
23,Risk-based capital,$ in millions; [Risk-based capital]; CET1 capital; Tier 1 capital; **Total capital**; **Total RWA**; [Risk-based capital ratios]; CET1 capital; Tier 1 capital; **Total capital**,Risk-based capital; Risk-based capital ratios,10q0325.pdf,27.096662030598054,docling
23,Risk-based capital,CET1 capital; Tier 1 capital; **Total capital**; [Required ratios]; CET1 capital; Tier 1 capital; **Total capital**,Required ratios,10q0325.pdf,27.096662030598054,docling
23,Leveraged-based capital,[Leveraged-based capital]; Adjusted average assets; Supplementary leverage exposure; [Leveraged-based capital ratios]; Tier 1 leverage; SLR; [Required ratios]; Tier 1 leverage; SLR,Leveraged-based capital; Leveraged-based capital ratios; Required ratios,10q0325.pdf,27.096662030598054,docling
23,Regulatory Capital,[CET1 capital]; Common shareholders' equity; [Regulatory adjustments and deductions:];   Net goodwill;   Net intangible assets;   Impact of CECL transition;   Other adjustments and deductions; **Total CET1 capital**; [Additional Tier 1 capital]; Preferred stock,CET1 capital; Regulatory adjustments and deductions:; Additional Tier 1 capital,10q0325.pdf,27.096662030598054,docling
23,Regulatory Capital,**Total CET1 capital**; [Additional Tier 1 capital]; Preferred stock; Noncontrolling interests; Additional Tier 1 capital; Deduction for investments in covered funds; **Total Tier 1 capital**; [Standardized Tier 2 capital]; Subordinated debt; Eligible ACL,Additional Tier 1 capital; Standardized Tier 2 capital,10q0325.pdf,27.096662030598054,docling
23,Regulatory Capital,[Standardized Tier 2 capital]; Subordinated debt; Eligible ACL; Other adjustments and deductions; **Total Standardized Tier 2 capital**; **Total Standardized capital**; [Advanced Tier 2 capital]; Subordinated debt; Eligible credit reserves; Other adjustments and deductions,Standardized Tier 2 capital; Advanced Tier 2 capital,10q0325.pdf,27.096662030598054,docling
23,Regulatory Capital,Subordinated debt; Eligible credit reserves; Other adjustments and deductions; **Total Advanced Tier 2 capital**; **Total Advanced capital**,,10q0325.pdf,27.096662030598054,docling
24,RWA Rollforward,"$ in millions; [Credit risk RWA]; Balance at December 31, 2024; [Change related to the following items:];   Derivatives;   Securities financing transactions;   Investment securities;   Commitments, guarantees and loans;   Equity investments;   Other credit risk",Credit risk RWA; Change related to the following items:,10q0325.pdf,27.096662030598054,docling
24,RWA Rollforward,"Commitments, guarantees and loans; Equity investments; Other credit risk; **Total change in credit risk RWA**; Balance at March 31, 2025; [Market risk RWA]; Balance at December 31, 2024; [Change related to the following items:];   Regulatory VaR;   Regulatory stressed VaR",Market risk RWA; Change related to the following items:,10q0325.pdf,27.096662030598054,docling
24,RWA Rollforward,"[Change related to the following items:];   Regulatory VaR;   Regulatory stressed VaR;   Incremental risk charge;   Comprehensive risk measure;   Specific risk; **Total change in market risk RWA**; Balance at March 31, 2025; [Operational risk RWA]; Balance at December 31, 2024",Change related to the following items:; Operational risk RWA,10q0325.pdf,27.096662030598054,docling
24,RWA Rollforward,"Balance at March 31, 2025; [Operational risk RWA]; Balance at December 31, 2024; Change in operational risk RWA; Balance at March 31, 2025; **Total RWA**",Operational risk RWA,10q0325.pdf,27.096662030598054,docling
24,Required and Actual TLAC and Eligible LTD Ratios,$ in millions; External TLAC; External TLAC asa% of RWA; External TLAC asa% of leverage exposure; Eligible LTD; Eligible LTD as a %of RWA; Eligible LTD as a %of leverage exposure,,10q0325.pdf,27.096662030598054,docling
25,Average  Common  Equity  Attribution  under  the  Required Capital Framework,$ in billions; Institutional Securities; Wealth Management; Investment Management; Parent Company; **Total**,,10q0325.pdf,27.096662030598054,docling
26,95%/One-Day Management VaR for the Trading Portfolio,$ in millions; Interest rate and credit spread; Equity price; Foreign exchange rate; Commodity price; Less: Diversification benefit; Primary Risk Categories; Credit Portfolio; Less: Diversification benefit; **Total Management VaR**,,10q0325.pdf,27.096662030598054,docling
26,95%/One-Day Management VaR for the Trading Portfolio,$ in millions; Interest rate and credit spread; Equity price; Foreign exchange rate; Commodity price; Less: Diversification benefit; Primary Risk Categories; Credit Portfolio; Less: Diversification benefit; **Total Management VaR**,,10q0325.pdf,27.096662030598054,docling
27,Credit Spread Risk Sensitivity,Derivatives; Borrowings carried at fair value,,10q0325.pdf,27.096662030598054,docling
27,Wealth Management Net Interest Income Sensitivity Analysis,[Basis point change]; +200; +100; -100; -200,Basis point change,10q0325.pdf,27.096662030598054,docling
28,"Investments Sensitivity, Including Related Carried Interest",$ in millions; Investments related to Investment Management activities; [Other investments:];   MUMSS;   Other Firm investments,Other investments:,10q0325.pdf,27.096662030598054,docling
28,Loans and Lending Commitments,$ in millions; [Institutional Securities:];   Corporate;   Secured lending facilities;   Commercial and Residential real estate;   Securities-based lending and Other; **Total Institutional Securities**; [Wealth Management:];   Residential real estate;   Securities-based lending and Other,Institutional Securities:; Wealth Management:,10q0325.pdf,27.096662030598054,docling
28,Loans and Lending Commitments,"[Wealth Management:];   Residential real estate;   Securities-based lending and Other; **Total Wealth Management**; **Total Investment Management**; **Total loans**; ACL; **Total loans, net of ACL**; Lending commitments; **Total exposure**",Wealth Management:,10q0325.pdf,27.096662030598054,docling
28,Loans and Lending Commitments,"**Total loans, net of ACL**; Lending commitments; **Total exposure**",,10q0325.pdf,27.096662030598054,docling
28,Loans and Lending Commitments,$ in millions; [Institutional Securities:];   Corporate;   Secured lending facilities;   Commercial and Residential real estate;   Securities-based lending and Other; **Total Institutional Securities**; [Wealth Management:];   Residential real estate;   Securities-based lending and Other,Institutional Securities:; Wealth Management:,10q0325.pdf,27.096662030598054,docling
28,Loans and Lending Commitments,"[Wealth Management:];   Residential real estate;   Securities-based lending and Other; **Total Wealth Management**; **Total Investment Management**; **Total loans**; ACL; **Total loans, net of ACL**; Lending commitments; **Total exposure**",Wealth Management:,10q0325.pdf,27.096662030598054,docling
28,Loans and Lending Commitments,"**Total loans, net of ACL**; Lending commitments; **Total exposure**",,10q0325.pdf,27.096662030598054,docling
29,Allowance for Credit Losses-Loans and Lending Commitments,[ACL-Loans]; Beginning balance; Gross charge-offs; Recoveries; Net (charge-offs)/recoveries; Provision for credit losses; Other; Ending balance; [ACL-Lending commitments]; Beginning balance,ACL-Loans; ACL-Lending commitments,10q0325.pdf,27.096662030598054,docling
29,Allowance for Credit Losses-Loans and Lending Commitments,Ending balance; [ACL-Lending commitments]; Beginning balance; Provision for credit losses; Other; Ending balance; **Total ending balance**,ACL-Lending commitments,10q0325.pdf,27.096662030598054,docling
29,Provision for Credit Losses by Business Segment,$ in millions; Loans; Lending commitments; **Total**,,10q0325.pdf,27.096662030598054,docling
29,Forecasted U.S. Real GDP Growth Rates in Base Scenario,Year-over-year growth rate,,10q0325.pdf,27.096662030598054,docling
29,Status of Loans Held for Investment,Accrual; Nonaccrual,,10q0325.pdf,27.096662030598054,docling
30,Net Charge-off Ratios for Loans Held for Investment,"For the Three Months Ended March 31, 2025; Net charge- off/(recovery) ratio; Average loans; CRE-Commercial real estate",,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments,"$ in millions; [Loans]; AA; A; BBB; BB; Other NIG; Unrated; **Total loans, net of ACL**; [Lending commitments]",Loans; Lending commitments,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments,"Unrated; **Total loans, net of ACL**; [Lending commitments]; AAA; AA; A; BBB; BB; Other NIG; Unrated",Lending commitments,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments,BB; Other NIG; Unrated; **Total lending commitments**; **Total exposure**,,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments,"$ in millions; [Loans]; AA; A; BBB; BB; Other NIG; Unrated; **Total loans, net of ACL**",Loans,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments,"Other NIG; Unrated; **Total loans, net of ACL**; Lending commitments AAA; AA; A; BBB; BB; Other NIG; Unrated",,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments,BB; Other NIG; Unrated; **Total lending commitments**; **Total exposure**,,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments by Industry,[Industry]; Financials; Real estate; Industrials; Information technology; Communications services; Consumer discretionary; Healthcare; Utilities; Consumer staples,Industry,10q0325.pdf,27.096662030598054,docling
30,Institutional Securities Loans and Lending Commitments by Industry,Healthcare; Utilities; Consumer staples; Energy; Materials; Insurance; Other; **Total exposure**,,10q0325.pdf,27.096662030598054,docling
31,Institutional Securities Event-Driven Loans and Lending Commitments,"$ in millions; Loans, net of ACL; Lending commitments; **Total exposure**",,10q0325.pdf,27.096662030598054,docling
31,Institutional Securities Event-Driven Loans and Lending Commitments,"$ in millions; Loans, net of ACL; Lending commitments; **Total exposure**",,10q0325.pdf,27.096662030598054,docling
31,Institutional  Securities  Loans  and  Lending  Commitments Held for Investment,"$ in millions; Corporate; Secured lending facilities; Commercial real estate; Securities-based lending and Other; **Total, before ACL**; ACL",,10q0325.pdf,27.096662030598054,docling
31,Institutional  Securities  Loans  and  Lending  Commitments Held for Investment,"$ in millions; Corporate; Secured lending facilities; Commercial real estate; Securities-based lending and Other; **Total, before ACL**; ACL",,10q0325.pdf,27.096662030598054,docling
31,By Region,$ in millions; Americas; EMEA; Asia; **Total**,,10q0325.pdf,27.096662030598054,docling
31,By Property Type,$ in millions; Office; Industrial; Multifamily; Retail; Hotel; **Total**,,10q0325.pdf,27.096662030598054,docling
32,Institutional  Securities  Allowance  for  Credit  Losses-Loans and Lending Commitments,$ in millions; [ACL-Loans]; Beginning balance; Gross charge-offs; Recoveries; Net (charge-offs)/ recoveries; Provision (release); Other; Ending balance; ACL-Lending commitments,ACL-Loans,10q0325.pdf,27.096662030598054,docling
32,Institutional  Securities  Allowance  for  Credit  Losses-Loans and Lending Commitments,Other; Ending balance; ACL-Lending commitments; Beginning balance; Provision (release); Other; Ending balance; **Total ending balance**,,10q0325.pdf,27.096662030598054,docling
32,Institutional  Securities  HFI  Loans-Ratios  of  Allowance  for Credit Losses to Balance Before All,Corporate; Secured lending facilities; Commercial real estate; Securities-based lending and Other; **Total Institutional Securities loans**,,10q0325.pdf,27.096662030598054,docling
32,Wealth Management Loans and Lending Commitments,"$ in millions; Securities-based lending and Other; Residential real estate; **Total loans, net of ACL**; Lending commitments; **Total exposure**",,10q0325.pdf,27.096662030598054,docling
32,Wealth Management Loans and Lending Commitments,"$ in millions; Securities-based lending and Other; Residential real estate; **Total loans, net of ACL**; Lending commitments; **Total exposure**",,10q0325.pdf,27.096662030598054,docling
32,Wealth  Management  Commercial  Real  Estate  Loans  and Lending Commitments by Property Type,$ in millions; Retail; Multifamily; Office; Industrial; Hotel; Other; **Total**,,10q0325.pdf,27.096662030598054,docling
32,Wealth Management Allowance for Credit Losses-Loans and Lending Commitments,$ in millions; [ACL-Loans]; Beginning balance; Provision (release); Ending balance; [ACL-Lending commitments]; Beginning balance; Ending balance; **Total ending balance**,ACL-Loans; ACL-Lending commitments,10q0325.pdf,27.096662030598054,docling
33,Margin Loans and Other Lending,Institutional Securities; Wealth Management; **Total**,,10q0325.pdf,27.096662030598054,docling
33,Fair Value of OTC Derivative Assets,"$ in millions; Less than 1 year; 1-3 years; 3-5 years; Over 5 years; **Total, gross**; Counterparty netting; Cash and securities collateral; **Total, net**",,10q0325.pdf,27.096662030598054,docling
33,Fair Value of OTC Derivative Assets,"$ in millions; Less than 1 year; 1-3 years; 3-5 years; Over 5 years; **Total, gross**; Counterparty netting; Cash and securities collateral; **Total, net**",,10q0325.pdf,27.096662030598054,docling
33,Fair Value of OTC Derivative Assets,[Industry]; Financials; Utilities; Industrials; Energy; Consumer discretionary; Communications services; Regional governments; Information technology; Consumer staples,Industry,10q0325.pdf,27.096662030598054,docling
33,Fair Value of OTC Derivative Assets,Regional governments; Information technology; Consumer staples; Sovereign governments; Healthcare; Materials; Insurance; Real estate; Not-for-profit organizations; Other,,10q0325.pdf,27.096662030598054,docling
33,Fair Value of OTC Derivative Assets,Real estate; Not-for-profit organizations; Other; **Total**,,10q0325.pdf,27.096662030598054,docling
34,Country Risk,$ in millions; [Sovereign]; Net inventory; Net counterparty exposure; Exposure before hedges; Hedges; Net exposure; [Non-sovereign]; Net inventory; Net counterparty exposure,Sovereign; Non-sovereign,10q0325.pdf,27.096662030598054,docling
34,Country Risk,[Non-sovereign]; Net inventory; Net counterparty exposure; Loans; Lending commitments; Exposure before hedges; Hedges; Net exposure; **Total net exposure**; $ in millions,Non-sovereign,10q0325.pdf,27.096662030598054,docling
34,Country Risk,Net exposure; **Total net exposure**; $ in millions; [Sovereign]; Net inventory; Net counterparty exposure; Exposure before hedges; Hedges; Net exposure; [Non-sovereign],Sovereign; Non-sovereign,10q0325.pdf,27.096662030598054,docling
34,Country Risk,Hedges; Net exposure; [Non-sovereign]; Net inventory; Net counterparty exposure; Loans; Lending commitments; Exposure before hedges; Hedges; Net exposure,Non-sovereign,10q0325.pdf,27.096662030598054,docling
34,Country Risk,Exposure before hedges; Hedges; Net exposure; **Total net exposure**,,10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,"in millions, except per share data; [Revenues]; Investment banking; Trading; Investments; Commissions and fees; Asset management; Other; **Total non-interest revenues**; Interest income",Revenues,10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,"Other; **Total non-interest revenues**; Interest income; Interest expense; Net interest; Net revenues; Provision for credit losses; [Non-interest expenses]; Compensation and benefits; Brokerage, clearing and exchange fees",Non-interest expenses,10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,"[Non-interest expenses]; Compensation and benefits; Brokerage, clearing and exchange fees; Information processing and communications; Professional services; Occupancy and equipment; Marketing and business development; Other; **Total non-interest expenses**; Income before provision for income taxes",Non-interest expenses,10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,Other; **Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes; Net income; Net income applicable to noncontrolling interests; Net income applicable to Morgan Stanley; Preferred stock dividends; Earnings applicable to Morgan Stanley common shareholders; [Earnings per common share],Earnings per common share,10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,Preferred stock dividends; Earnings applicable to Morgan Stanley common shareholders; [Earnings per common share]; Basic; Diluted; [Average common shares outstanding]; Basic; Diluted,Earnings per common share; Average common shares outstanding,10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,"$ in millions; Net income; [Other comprehensive income (loss), net of tax:];   Foreign currency translation adjustments;   Change in net unrealized gains (losses) on available-for-sale securities;   Pension and other;   Change in net debt valuation adjustment;   Net change in cash flow hedges; **Total other comprehensive income (loss)**; Comprehensive income","Other comprehensive income (loss), net of tax:",10q0325.pdf,27.096662030598054,docling
37,Basis for Review Results,Net change in cash flow hedges; **Total other comprehensive income (loss)**; Comprehensive income; Net income applicable to noncontrolling interests; Other comprehensive income (loss) applicable to noncontrolling interests; Comprehensive income applicable to Morgan Stanley,,10q0325.pdf,27.096662030598054,docling
38,Consolidated Balance Sheet,"[Assets]; Cash and cash equivalents; $203,124; [Investment securities:];   $101,770;   $50,549;   Securities purchased under agreements to resell (includes $- and $-at fair value);   Securities borrowed;   Customer and other receivables; [Loans:]",Assets; Investment securities:; Loans:,10q0325.pdf,27.096662030598054,docling
38,Consolidated Balance Sheet,"Securities borrowed; Customer and other receivables; [Loans:];   $1,133;   Held for sale;   Goodwill;   $5,585;   Other assets; **Total assets**; [Liabilities]",Loans:; Liabilities,10q0325.pdf,27.096662030598054,docling
38,Consolidated Balance Sheet,"Other assets; **Total assets**; [Liabilities]; $6,681; Trading liabilities at fair value; $986; Securities loaned; $17,757; Customer and other payables; Other liabilities and accrued expenses",Liabilities,10q0325.pdf,27.096662030598054,docling
38,Consolidated Balance Sheet,"$17,757; Customer and other payables; Other liabilities and accrued expenses; $112,094; **Total liabilities**; [Commitments and contingent liabilities (see Note 13)]; [Equity]; [Morgan Stanley shareholders' equity:];   Preferred stock;   $,",Commitments and contingent liabilities (see Note 13); Equity; Morgan Stanley shareholders' equity:,10q0325.pdf,27.096662030598054,docling
38,Consolidated Balance Sheet,"[Morgan Stanley shareholders' equity:];   Preferred stock;   $,;   Shares authorized: 3,500,000,000 ; Shares issued: 2,038,893,979 ; Shares outstanding: 1,606,806,297 and 1,606,653,706;   Additional paid-in capital;   Retained earnings;   Employee stock trusts;   Accumulated other comprehensive income (loss);   $,;   Common stock issued to employee stock trusts",Morgan Stanley shareholders' equity:,10q0325.pdf,27.096662030598054,docling
38,Consolidated Balance Sheet,"Accumulated other comprehensive income (loss); $,; Common stock issued to employee stock trusts; **Total Morgan Stanley shareholders' equity**; Noncontrolling interests; **Total equity**; **Total liabilities and equity**",,10q0325.pdf,27.096662030598054,docling
39,Consolidated Balance Sheet,$ in millions; [Preferred stock]; Beginning and ending balance; [Common stock]; Beginning and ending balance; [Additional paid-in capital]; Beginning balance; Share-based award activity; Ending balance; [Retained earnings],Preferred stock; Common stock; Additional paid-in capital; Retained earnings,10q0325.pdf,27.096662030598054,docling
39,Consolidated Balance Sheet,Share-based award activity; Ending balance; [Retained earnings]; Beginning balance; Cumulative adjustment related to the adoption of an accounting standard update; Net income applicable to Morgan Stanley; Preferred stock dividends; Common stock dividends; Other net increases (decreases); Ending balance,Retained earnings,10q0325.pdf,27.096662030598054,docling
39,Consolidated Balance Sheet,Common stock dividends; Other net increases (decreases); Ending balance; [Employee stock trusts]; Beginning balance; Share-based award activity; Ending balance; [Accumulated other comprehensive income (loss)]; Beginning balance; Net change in Accumulated other comprehensive income (loss),Employee stock trusts; Accumulated other comprehensive income (loss),10q0325.pdf,27.096662030598054,docling
39,Consolidated Balance Sheet,[Accumulated other comprehensive income (loss)]; Beginning balance; Net change in Accumulated other comprehensive income (loss); Ending balance; [Common stock held in treasury at cost]; Beginning balance; Share-based award activity; Repurchases of common stock and employee tax withholdings; Ending balance; [Common stock issued to employee stock trusts],Accumulated other comprehensive income (loss); Common stock held in treasury at cost; Common stock issued to employee stock trusts,10q0325.pdf,27.096662030598054,docling
39,Consolidated Balance Sheet,Repurchases of common stock and employee tax withholdings; Ending balance; [Common stock issued to employee stock trusts]; Beginning balance; Share-based award activity; Ending balance; [Noncontrolling interests]; Beginning balance; Net income applicable to noncontrolling interests; Net change in Accumulated other comprehensive income (loss) applicable to noncontrolling interests,Common stock issued to employee stock trusts; Noncontrolling interests,10q0325.pdf,27.096662030598054,docling
39,Consolidated Balance Sheet,Beginning balance; Net income applicable to noncontrolling interests; Net change in Accumulated other comprehensive income (loss) applicable to noncontrolling interests; Other net increases (decreases); Ending balance; **Total equity**,,10q0325.pdf,27.096662030598054,docling
40,(Page 40),"$ in millions; [Cash flows from operating activities]; Net income; [Adjustments to reconcile net income to net cash provided by (used for) operating activities:];   Stock-based compensation expense;   Depreciation and amortization;   Provision for credit losses;   Other operating adjustments; [Changes in assets and liabilities:];   Trading assets, net of Trading liabilities",Cash flows from operating activities; Adjustments to reconcile net income to net cash provided by (used for) operating activities:; Changes in assets and liabilities:,10q0325.pdf,27.096662030598054,docling
40,(Page 40),"Other operating adjustments; [Changes in assets and liabilities:];   Trading assets, net of Trading liabilities;   Securities borrowed;   Securities loaned;   Customer and other receivables and other assets;   Customer and other payables and other liabilities;   Securities purchased under agreements to resell;   Securities sold under agreements to repurchase;   Net cash provided by (used for) operating activities",Changes in assets and liabilities:,10q0325.pdf,27.096662030598054,docling
40,(Page 40),"Securities purchased under agreements to resell; Securities sold under agreements to repurchase; Net cash provided by (used for) operating activities; [Cash flows from investing activities]; [Proceeds from (payments for):];   Other assets-Premises, equipment and software;   Changes in loans, net; [AFS securities:];   Purchases;   Proceeds from sales",Cash flows from investing activities; Proceeds from (payments for):; AFS securities:,10q0325.pdf,27.096662030598054,docling
40,(Page 40),[AFS securities:];   Purchases;   Proceeds from sales;   Proceeds from paydowns and maturities; [HTM securities:];   Purchases;   Proceeds from paydowns and maturities;   Other investing activities;   Net cash provided by (used for) investing activities; [Cash flows from financing activities],AFS securities:; HTM securities:; Cash flows from financing activities,10q0325.pdf,27.096662030598054,docling
40,(Page 40),Other investing activities; Net cash provided by (used for) investing activities; [Cash flows from financing activities]; [Net proceeds from (payments for):];   Other secured financings;   Deposits;   Proceeds from issuance of Borrowings; [Payments for:];   Borrowings;   Repurchases of common stock and employee tax withholdings,Cash flows from financing activities; Net proceeds from (payments for):; Payments for:,10q0325.pdf,27.096662030598054,docling
40,(Page 40),"[Payments for:];   Borrowings;   Repurchases of common stock and employee tax withholdings;   Cash dividends;   Other financing activities;   Net cash provided by (used for) financing activities;   Effect of exchange rate changes on cash and cash equivalents;   Net increase (decrease) in cash and cash equivalents;   Cash and cash equivalents, at beginning of period;   Cash and cash equivalents, at end of period",Payments for:,10q0325.pdf,27.096662030598054,docling
40,(Page 40),"Net increase (decrease) in cash and cash equivalents; Cash and cash equivalents, at beginning of period; Cash and cash equivalents, at end of period; [Supplemental Disclosure of Cash Flow Information]; [Cash payments for:];   Interest;   Income taxes, net of refunds",Supplemental Disclosure of Cash Flow Information; Cash payments for:,10q0325.pdf,27.096662030598054,docling
42,Cash and Cash Equivalents,Cash and due from banks; Interest bearing deposits with banks; **Total Cash and cash equivalents**; Restricted cash,,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,"$ in millions; [Assets at fair value]; [Trading assets:];   U.S. Treasury and agency securities;   Other sovereign government obligations;   State and municipal securities;   MABS;   Loans and lending commitments;   Corporate and other debt;   Corporate equities 3,5",Assets at fair value; Trading assets:,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,"Loans and lending commitments; Corporate and other debt; Corporate equities 3,5; Derivative and other contracts:;   Interest rate;   Credit;   Foreign exchange;   Equity;   Commodity and other;   Netting",,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,"Equity; Commodity and other; Netting; **Total derivative and other contracts**; Investments 4,5; Physical commodities; **Total trading assets**; Investment securities-AFS; **Total assets at fair value**",,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,$ in millions; [Liabilities at fair value]; Deposits; [Trading liabilities:];   U.S. Treasury and agency securities;   Other sovereign government obligations;   Corporate and other debt;   Corporate equities; [Derivative and other contracts:];   Interest rate,Liabilities at fair value; Trading liabilities:; Derivative and other contracts:,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,Corporate equities; [Derivative and other contracts:];   Interest rate;   Credit;   Foreign exchange;   Equity;   Commodity and other;   Netting; **Total derivative and other contracts**; **Total trading liabilities**,Derivative and other contracts:,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,Netting; **Total derivative and other contracts**; **Total trading liabilities**; Securities sold under agreements to repurchase; Other secured financings; Borrowings; **Total liabilities at fair value**,,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,"$ in millions; [Assets at fair value]; [Trading assets:];   U.S. Treasury and agency securities;   Other sovereign government obligations;   State and municipal securities;   MABS;   Loans and lending commitments;   Corporate and other debt;   Corporate equities 3,5",Assets at fair value; Trading assets:,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,"Loans and lending commitments; Corporate and other debt; Corporate equities 3,5; Derivative and other contracts:;   Interest rate;   Credit;   Foreign exchange;   Equity;   Commodity and other;   Netting",,10q0325.pdf,27.096662030598054,docling
42,Assets and Liabilities Measured at Fair Value on a Recurring Basis,"Equity; Commodity and other; Netting; **Total derivative and other contracts**; Investments 4,5; Physical commodities; **Total trading assets**; Investment securities-AFS; **Total assets at fair value**",,10q0325.pdf,27.096662030598054,docling
43,Assets and Liabilities Measured at Fair Value on a Recurring Basis,$ in millions; [Liabilities at fair value]; Deposits; [Trading liabilities:];   U.S. Treasury and agency securities;   Other sovereign government obligations;   Corporate and other debt;   Corporate equities; [Derivative and other contracts:];   Interest rate,Liabilities at fair value; Trading liabilities:; Derivative and other contracts:,10q0325.pdf,27.096662030598054,docling
43,Assets and Liabilities Measured at Fair Value on a Recurring Basis,Corporate equities; [Derivative and other contracts:];   Interest rate;   Credit;   Foreign exchange;   Equity;   Commodity and other;   Netting; **Total derivative and other contracts**; **Total trading liabilities**,Derivative and other contracts:,10q0325.pdf,27.096662030598054,docling
43,Assets and Liabilities Measured at Fair Value on a Recurring Basis,Netting; **Total derivative and other contracts**; **Total trading liabilities**; Securities sold under agreements to repurchase; Other secured financings; Borrowings; **Total liabilities at fair value**,,10q0325.pdf,27.096662030598054,docling
43,Detail of Loans and Lending Commitments at Fair Value,Commercial real estate; Residential real estate; Securities-based lending and Other loans; **Total**,,10q0325.pdf,27.096662030598054,docling
43,Unsettled Fair Value of Futures Contracts,"Customer and other receivables (payables), net",,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,$ in millions; [Other sovereign government obligations]; Beginning balance; Realized and unrealized gains (losses); Purchases; Sales; Net transfers; Ending balance; Unrealized gains (losses); [State and municipal securities],Other sovereign government obligations; State and municipal securities,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Ending balance; Unrealized gains (losses); [State and municipal securities]; Beginning balance; Purchases; Sales; Net transfers; Ending balance; [Unrealized gains (losses)]; [MABS],State and municipal securities; Unrealized gains (losses); MABS,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Ending balance; [Unrealized gains (losses)]; [MABS]; Beginning balance; Realized and unrealized gains (losses); Purchases; Sales; Net transfers; Ending balance; Unrealized gains (losses),Unrealized gains (losses); MABS,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Net transfers; Ending balance; Unrealized gains (losses); [Loans and lending commitments]; Beginning balance; Realized and unrealized gains (losses); Purchases and originations; Sales; Settlements; Net transfers,Loans and lending commitments,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Sales; Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Corporate and other debt]; Beginning balance; Realized and unrealized gains (losses); Purchases and originations; Sales,Corporate and other debt,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Realized and unrealized gains (losses); Purchases and originations; Sales; Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Corporate equities]; Beginning balance; Realized and unrealized gains (losses),Corporate equities,10q0325.pdf,27.096662030598054,docling
43,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,[Corporate equities]; Beginning balance; Realized and unrealized gains (losses); Purchases; Sales; Net transfers; Ending balance; Unrealized gains (losses),Corporate equities,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,$ in millions; [Investments]; Beginning balance; Realized and unrealized gains (losses); Purchases; Sales; Net transfers; Ending balance; Unrealized gains (losses); [Net derivatives: Interest rate],Investments; Net derivatives: Interest rate,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Ending balance; Unrealized gains (losses); [Net derivatives: Interest rate]; Beginning balance; Realized and unrealized gains (losses); Purchases; Issuances; Settlements; Net transfers; Ending balance,Net derivatives: Interest rate,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Net derivatives: Credit]; Beginning balance; Realized and unrealized gains (losses); Settlements; Net transfers; Ending balance,Net derivatives: Credit,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Net derivatives: Foreign exchange]; Beginning balance; Realized and unrealized gains (losses); Purchases; Settlements; Net transfers,Net derivatives: Foreign exchange,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Purchases; Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Net derivatives: Equity]; Beginning balance; Realized and unrealized gains (losses); Purchases; Issuances,Net derivatives: Equity,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Realized and unrealized gains (losses); Purchases; Issuances; Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Net derivatives: Commodity and other]; Beginning balance; Realized and unrealized gains (losses),Net derivatives: Commodity and other,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,[Net derivatives: Commodity and other]; Beginning balance; Realized and unrealized gains (losses); Purchases; Issuances; Settlements; Net transfers; Ending balance; Unrealized gains (losses); [Deposits],Net derivatives: Commodity and other; Deposits,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Ending balance; Unrealized gains (losses); [Deposits]; Beginning balance; Realized and unrealized losses (gains); Issuances; Settlements; Net transfers; Ending balance; Unrealized losses (gains),Deposits,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Net transfers; Ending balance; Unrealized losses (gains),,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,$ in millions; [Nonderivative trading liabilities]; Beginning balance; Realized and unrealized losses (gains); Purchases; Sales; Net transfers; Ending balance; Unrealized losses (gains); Securities sold under agreements to repurchase,Nonderivative trading liabilities,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Ending balance; Unrealized losses (gains); Securities sold under agreements to repurchase; Beginning balance; Realized and unrealized losses (gains); Net transfers; Ending balance; Unrealized losses (gains); [Other secured financings]; Beginning balance,Other secured financings,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Unrealized losses (gains); [Other secured financings]; Beginning balance; Realized and unrealized losses (gains); Issuances; Settlements; Net transfers; Ending balance; Unrealized losses (gains); [Borrowings],Other secured financings; Borrowings,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Ending balance; Unrealized losses (gains); [Borrowings]; Beginning balance; Realized and unrealized losses (gains); Issuances; Settlements; Net transfers; Ending balance; Unrealized losses (gains),Borrowings,10q0325.pdf,27.096662030598054,docling
44,Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis,Net transfers; Ending balance; Unrealized losses (gains); Portion of Unrealized losses (gains) recorded in OCI-Change in net DVA,,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,"$ in millions, except inputs; Assets at Fair Value on a Recurring Basis; Other sovereign; government obligations; Comparable pricing:;   Bond price;   MABS;   Comparable pricing: Bond price;   Loans and lending commitments;   Margin loan model: Margin loan rate",,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,Comparable pricing: Bond price; Loans and lending commitments; Margin loan model: Margin loan rate; Loan price; Corporate and other debt; Comparable pricing: Bond price; Discounted cash flow: Loss given default; Corporate equities Comparable pricing:;   Equity price;   Investments flow:,,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,Corporate equities Comparable pricing:;   Equity price;   Investments flow:;   Discounted cash WACC;   Exit multiple;   Market approach: EBITDA multiple;   Comparable pricing: Equity price;   Net derivative and other contracts: Interest rate;   Option model: IR volatility skew IR curve correlation;   Bond volatility Inflation volatility,,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,Net derivative and other contracts: Interest rate; Option model: IR volatility skew IR curve correlation; Bond volatility Inflation volatility; Credit Credit default swap model:;   Cash-synthetic basis;   Bond price;   Credit spread Funding spread;   Foreign exchange; [Option model:],Option model:,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,Credit spread Funding spread; Foreign exchange; [Option model:];   IR curve;   Contingency probability,Option model:,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,"$ in millions, except inputs; Equity; [Option model:];   Equity volatility;   Equity volatility skew;   Equity correlation;   FX correlation;   IR correlation;   Commodity and other; [Option model:]",Option model:; Option model:,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,IR correlation; Commodity and other; [Option model:];   Forward power price;   Commodity volatility;   Cross-commodity correlation;   Liabilities Measured at Fair Value on a Recurring Basis;   Securities sold under agreements to repurchase; [Discounted cash flow:];   Funding spread,Option model:; Discounted cash flow:,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,Securities sold under agreements to repurchase; [Discounted cash flow:];   Funding spread;   Other secured financings; [Comparable pricing:];   Loan price;   Borrowings; [Option model:];   Equity volatility;   Equity volatility skew,Discounted cash flow:; Comparable pricing:; Option model:,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,[Option model:];   Equity volatility;   Equity volatility skew;   Equity correlation;   Equity - FX correlation;   Credit spread; [Discounted cash flow:];   Loans; [Nonrecurring Fair Value],Option model:; Discounted cash flow:; Nonrecurring Fair Value,10q0325.pdf,27.096662030598054,docling
45,Valuation Techniques and Unobservable Inputs,Loans; [Nonrecurring Fair Value]; [Corporate loan model:];   Credit spread; [Comparable pricing:];   Loan price;   Credit spread;   Warehouse model:,Nonrecurring Fair Value; Corporate loan model:; Comparable pricing:,10q0325.pdf,27.096662030598054,docling
46,Fund Interests,$ in millions; Private equity and other; Real estate; Hedge; **Total**,,10q0325.pdf,27.096662030598054,docling
46,Nonredeemable Funds by Contractual Maturity,$ in millions; Less than 5 years; 5-10 years; Over 10 years; **Total**,,10q0325.pdf,27.096662030598054,docling
46,Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis,$ in millions; [Assets]; Loans; Other assets-Other investments; **Total**; [Liabilities]; Other liabilities and accrued expenses- Lending commitments; **Total**,Assets; Liabilities,10q0325.pdf,27.096662030598054,docling
46,Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis,$ in millions; [Assets]; Loans; Other assets-Other investments; Other assets-ROU assets; **Total**; [Liabilities]; Other liabilities and accrued expenses- Lending commitments; **Total**,Assets; Liabilities,10q0325.pdf,27.096662030598054,docling
46,Gains (Losses) from Nonrecurring Fair Value Remeasurements,"$ in millions; [Assets]; Loans; Other assets-Other investments; Other assets-Premises, equipment and software; **Total**; [Liabilities]; Other liabilities and accrued expenses- Lending commitments; **Total**",Assets; Liabilities,10q0325.pdf,27.096662030598054,docling
47,Financial Instruments Not Measured at Fair Value,$ in millions; [Financial assets]; Cash and cash equivalents; Investment securities- HTM; Securities purchased under agreements to resell; Securities borrowed; Customer and other receivables; [Loans]; Held for investment,Financial assets; Loans,10q0325.pdf,27.096662030598054,docling
47,Financial Instruments Not Measured at Fair Value,Customer and other receivables; [Loans]; Held for investment; Held for sale; Other assets; [Financial liabilities]; Deposits; Securities sold under agreements to repurchase; Securities loaned; Other secured financings,Loans; Financial liabilities,10q0325.pdf,27.096662030598054,docling
47,Financial Instruments Not Measured at Fair Value,Securities sold under agreements to repurchase; Securities loaned; Other secured financings; Customer and other payables; Borrowings; Lending commitments,,10q0325.pdf,27.096662030598054,docling
47,Financial Instruments Not Measured at Fair Value,$ in millions; [Financial assets]; Cash and cash equivalents; Investment securities- HTM; Securities purchased under agreements to resell; Securities borrowed; Customer and other receivables; [Loans]; Held for investment,Financial assets; Loans,10q0325.pdf,27.096662030598054,docling
47,Financial Instruments Not Measured at Fair Value,Customer and other receivables; [Loans]; Held for investment; Held for sale; Other assets; [Financial liabilities]; Deposits; Securities sold under agreements to repurchase; Securities loaned; Other secured financings,Loans; Financial liabilities,10q0325.pdf,27.096662030598054,docling
47,Financial Instruments Not Measured at Fair Value,Securities sold under agreements to repurchase; Securities loaned; Other secured financings; Customer and other payables; Borrowings; Lending commitments,,10q0325.pdf,27.096662030598054,docling
47,Borrowings Measured at Fair Value on a Recurring Basis,Business Unit Responsible for Risk Management; Equity; Interest rates; Commodities; Credit; Foreign exchange; **Total**,,10q0325.pdf,27.096662030598054,docling
48,Net Revenues from Liabilities under the Fair Value Option,"[Three Months Ended March 31, 2025]; Borrowings; Deposits; [Three Months Ended March 31, 2024]; Borrowings","Three Months Ended March 31, 2025; Three Months Ended March 31, 2024",10q0325.pdf,27.096662030598054,docling
48,Gains (Losses) Due to Changes in Instrument-Specific Credit Risk,$ in millions; Loans and other receivables; Lending commitments; Deposits; Borrowings,,10q0325.pdf,27.096662030598054,docling
48,Gains (Losses) Due to Changes in Instrument-Specific Credit Risk,Cumulative pre-tax DVA gain (loss) recognized in AOCI,,10q0325.pdf,27.096662030598054,docling
48,Difference Between Contractual Principal and Fair Value,Loans and other receivables; Nonaccrual loans; Borrowings,,10q0325.pdf,27.096662030598054,docling
48,Fair Value Loans on Nonaccrual Status,Nonaccrual loans; Nonaccrual loans 90 or more days past due,,10q0325.pdf,27.096662030598054,docling
48,Fair Values of Derivative Contracts,$ in millions; [Designated as accounting hedges]; Interest rate; Foreign exchange; **Total**; [Not designated as accounting hedges]; Economic hedges of loans Credit; [Other derivatives]; Interest rate; Credit,Designated as accounting hedges; Not designated as accounting hedges; Other derivatives,10q0325.pdf,27.096662030598054,docling
48,Fair Values of Derivative Contracts,[Other derivatives]; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**; **Total gross derivatives**; [Amounts offset]; Counterparty netting,Other derivatives; Amounts offset,10q0325.pdf,27.096662030598054,docling
48,Fair Values of Derivative Contracts,**Total gross derivatives**; [Amounts offset]; Counterparty netting; Cash collateral netting; **Total in Trading assets**; [Amounts not offset]; Financial instruments collateral; Net amounts; Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable,Amounts offset; Amounts not offset,10q0325.pdf,27.096662030598054,docling
48,Fair Values of Derivative Contracts,$ in millions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; Economic hedges of loans Credit; [Other derivatives]; Interest rate; Credit,Other derivatives,10q0325.pdf,27.096662030598054,docling
48,Fair Values of Derivative Contracts,[Other derivatives]; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**; **Total gross derivatives**; [Amounts offset]; Counterparty netting,Other derivatives; Amounts offset,10q0325.pdf,27.096662030598054,docling
48,Fair Values of Derivative Contracts,**Total gross derivatives**; [Amounts offset]; Counterparty netting; Cash collateral netting; **Total in Trading liabilities**; [Amounts not offset]; Financial instruments collateral; Net amounts; Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable,Amounts offset; Amounts not offset,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,$ in millions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; Economic hedges of loans Credit; [Other derivatives]; Interest rate; Credit,Other derivatives,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,[Other derivatives]; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**; **Total gross derivatives**; [Amounts offset]; Counterparty netting,Other derivatives; Amounts offset,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,**Total gross derivatives**; [Amounts offset]; Counterparty netting; Cash collateral netting; **Total in Trading assets**; [Amounts not offset]; Financial instruments collateral; Net amounts; Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable,Amounts offset; Amounts not offset,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,Net amounts; Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable; $ in millions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; Economic hedges of loans Credit,,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,**Total**; Not designated as accounting hedges; Economic hedges of loans Credit; [Other derivatives]; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**,Other derivatives,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,Equity; Commodity and other; **Total**; **Total gross derivatives**; [Amounts offset]; Counterparty netting; Cash collateral netting; **Total in Trading liabilities**; [Amounts not offset]; Financial instruments collateral,Amounts offset; Amounts not offset,10q0325.pdf,27.096662030598054,docling
49,Fair Values of Derivative Contracts,**Total in Trading liabilities**; [Amounts not offset]; Financial instruments collateral; Net amounts; Net amounts for which master netting or collateral not in place or may not be legally,Amounts not offset,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,$ in billions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; Economic hedges of loans; [Credit]; Other derivatives; Interest rate,Credit,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,[Credit]; Other derivatives; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**; **Total gross derivatives**,Credit,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,**Total**; **Total gross derivatives**; $ in billions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; Economic hedges of loans Credit,,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,**Total**; Not designated as accounting hedges; Economic hedges of loans Credit; Other derivatives; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**,,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,Equity; Commodity and other; **Total**; **Total gross derivatives**; $ in billions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**,,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; Economic hedges of loans; [Credit]; Other derivatives; Interest rate; Credit; Foreign exchange,Credit,10q0325.pdf,27.096662030598054,docling
49,Notionals of Derivative Contracts,Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**; **Total gross derivatives**,,10q0325.pdf,27.096662030598054,docling
50,Notionals of Derivative Contracts,$ in billions; Designated as accounting hedges; Interest rate; Foreign exchange; **Total**; Not designated as accounting hedges; [Economic hedges of loans]; Credit; [Other derivatives]; Interest rate,Economic hedges of loans; Other derivatives,10q0325.pdf,27.096662030598054,docling
50,Notionals of Derivative Contracts,Credit; [Other derivatives]; Interest rate; Credit; Foreign exchange; Equity; Commodity and other; **Total**; **Total gross derivatives**,Other derivatives,10q0325.pdf,27.096662030598054,docling
50,Gains (Losses) on Accounting Hedges,$ in millions; Fair value hedges-Recognized in Interest income; Interest rate contracts; Investment Securities-AFS; Fair value hedges-Recognized in Interest expense; Interest rate contracts; Deposits; Borrowings; Net investment hedges-Foreign exchange contracts; Recognized in OCI,,10q0325.pdf,27.096662030598054,docling
50,Gains (Losses) on Accounting Hedges,Borrowings; Net investment hedges-Foreign exchange contracts; Recognized in OCI; Forward points excluded from hedge effectiveness testing-Recognized in Interest income; Cash flow hedges-Interest rate contracts; Recognized in OCI; Less: Realized gains (losses) (pre-tax) reclassified from AOCI to interest income; Net change in cash flow hedges included within AOCI,,10q0325.pdf,27.096662030598054,docling
50,Fair Value Hedges-Hedged Items,[Investment Securities-AFS]; Amortized cost basis currently or previously hedged; Basis adjustments included in amortized cost; [Deposits]; Carrying amountcurrently or previously hedged; Basis adjustments included in carrying amount; [Borrowings]; Carrying amountcurrently or previously hedged; Basis adjustments included in carrying amount - Outstanding hedges; Basis adjustments included in carrying amount - Terminated hedges,Investment Securities-AFS; Deposits; Borrowings,10q0325.pdf,27.096662030598054,docling
50,Gains (Losses) on Economic Hedges of Loans,$ in millions; [Recognized in Other revenues]; Credit contracts,Recognized in Other revenues,10q0325.pdf,27.096662030598054,docling
50,Net Derivative Liabilities and Collateral Posted,Net derivative liabilities with credit risk-related contingent features; Collateral posted,,10q0325.pdf,27.096662030598054,docling
50,Incremental Collateral and Termination Payments upon Potential Future Ratings Downgrade,One-notch downgrade; Two-notch downgrade; Bilateral downgrade agreements included in the amounts above,,10q0325.pdf,27.096662030598054,docling
51,Maximum  Potential Payout/Notional of Credit Protection Sold,$ in billions; [Single-name CDS]; Investment grade; Non-investment grade; **Total**; [Index and basket CDS]; Investment grade; Non-investment grade; **Total**; **Total CDS sold**,Single-name CDS; Index and basket CDS,10q0325.pdf,27.096662030598054,docling
51,Maximum  Potential Payout/Notional of Credit Protection Sold,Non-investment grade; **Total**; **Total CDS sold**; Other credit contracts; **Total credit protection sold**; CDS protection sold with identical protection purchased,,10q0325.pdf,27.096662030598054,docling
51,Maximum  Potential Payout/Notional of Credit Protection Sold,$ in billions; [Single-name CDS]; Investment grade; Non-investment grade; **Total**; [Index and basket CDS]; Investment grade; Non-investment grade; **Total**; **Total CDS sold**,Single-name CDS; Index and basket CDS,10q0325.pdf,27.096662030598054,docling
51,Maximum  Potential Payout/Notional of Credit Protection Sold,Non-investment grade; **Total**; **Total CDS sold**; Other credit contracts; **Total credit protection sold**; CDS protection sold with identical protection purchased,,10q0325.pdf,27.096662030598054,docling
51,Fair Value Asset (Liability) of Credit Protection Sold,[Single-name CDS]; Investment grade; Non-investment grade; **Total**; [Index and basket CDS]; Investment grade; Non-investment grade; **Total**; **Total CDS sold**; Other credit contracts,Single-name CDS; Index and basket CDS,10q0325.pdf,27.096662030598054,docling
51,Fair Value Asset (Liability) of Credit Protection Sold,**Total**; **Total CDS sold**; Other credit contracts; **Total credit protection sold**,,10q0325.pdf,27.096662030598054,docling
51,Protection Purchased with CDS,$ in billions; Single name; Index and basket; Tranched index and basket; **Total**,,10q0325.pdf,27.096662030598054,docling
51,Protection Purchased with CDS,$ in millions; Single name; Index and basket; Tranched index and basket; **Total**,,10q0325.pdf,27.096662030598054,docling
52,AFS and HTM Securities,$ in millions; [AFS securities]; U.S. Treasury securities; U.S. agency securities; Agency CMBS; State and municipal securities; FFELP student loan ABS; [Unallocated basis adjustment]; **Total AFS securities**; [HTM securities],AFS securities; Unallocated basis adjustment; HTM securities,10q0325.pdf,27.096662030598054,docling
52,AFS and HTM Securities,[Unallocated basis adjustment]; **Total AFS securities**; [HTM securities]; U.S. Treasury securities; U.S. agency securities; Agency CMBS; Non-agency CMBS; **Total HTM securities**; **Total investment securities**,Unallocated basis adjustment; HTM securities,10q0325.pdf,27.096662030598054,docling
52,AFS and HTM Securities,$ in millions; [AFS securities]; U.S. Treasury securities; U.S. agency securities; Agency CMBS; State and municipal securities; FFELP student loan ABS; Unallocated basis adjustment; **Total AFS securities**; [HTM securities],AFS securities; HTM securities,10q0325.pdf,27.096662030598054,docling
52,AFS and HTM Securities,Unallocated basis adjustment; **Total AFS securities**; [HTM securities]; U.S. Treasury securities; U.S. agency securities; Agency CMBS; Non-agency CMBS; **Total HTM securities**; **Total investment securities**,HTM securities,10q0325.pdf,27.096662030598054,docling
52,AFS Securities in an Unrealized Loss Position,$ in millions; [U.S. Treasury securities]; Less than 12 months; 12 months or longer; **Total**; [U.S. agency securities]; Less than 12 months; 12 months or longer; **Total**; [Agency CMBS],U.S. Treasury securities; U.S. agency securities; Agency CMBS,10q0325.pdf,27.096662030598054,docling
52,AFS Securities in an Unrealized Loss Position,12 months or longer; **Total**; [Agency CMBS]; 12 months or longer; **Total**; [State and municipal securities]; Less than 12 months; 12 months or longer; **Total**; [FFELP student loan ABS],Agency CMBS; State and municipal securities; FFELP student loan ABS,10q0325.pdf,27.096662030598054,docling
52,AFS Securities in an Unrealized Loss Position,12 months or longer; **Total**; [FFELP student loan ABS]; Less than 12 months; 12 months or longer; **Total**; **Total AFS securities in an unrealized loss position**; Less than 12 months; 12 months or longer; **Total**,FFELP student loan ABS,10q0325.pdf,27.096662030598054,docling
52,AFS Securities in an Unrealized Loss Position,Less than 12 months; 12 months or longer; **Total**,,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,$ in millions; [AFS securities]; [U.S. Treasury securities:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years; **Total**; [U.S. agency securities:];   Due within 1 year,AFS securities; U.S. Treasury securities:; U.S. agency securities:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,**Total**; [U.S. agency securities:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years; **Total**; [Agency CMBS:];   Due within 1 year;   After 1 year through 5 years,U.S. agency securities:; Agency CMBS:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,[Agency CMBS:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years; **Total**; [State and municipal securities:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years,Agency CMBS:; State and municipal securities:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,Due within 1 year; After 1 year through 5 years; After 5 years through 10 years; After 10 Years; **Total**; [FFELP student loan ABS:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years,FFELP student loan ABS:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,After 1 year through 5 years; After 5 years through 10 years; After 10 years; **Total**; [Unallocated basis adjustment]; **Total AFS securities**,Unallocated basis adjustment,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,$ in millions; [HTM securities]; [U.S. Treasury securities:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years; **Total**; [U.S. agency securities:];   Due within 1 year,HTM securities; U.S. Treasury securities:; U.S. agency securities:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,**Total**; [U.S. agency securities:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years; **Total**; [Agency CMBS:];   Due within 1 year;   After 1 year through 5 years,U.S. agency securities:; Agency CMBS:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,[Agency CMBS:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years;   After 10 years; **Total**; [Non-agency CMBS:];   Due within 1 year;   After 1 year through 5 years;   After 5 years through 10 years,Agency CMBS:; Non-agency CMBS:,10q0325.pdf,27.096662030598054,docling
53,Investment Securities by Contractual Maturity,Due within 1 year; After 1 year through 5 years; After 5 years through 10 years; After 10 years; **Total**; **Total HTM securities**; **Total investment securities**,,10q0325.pdf,27.096662030598054,docling
53,Gross Realized Gains (Losses) on Sales of AFS Securities,$ in millions; Gross realized gains; [Gross realized (losses)]; **Total**,Gross realized (losses),10q0325.pdf,27.096662030598054,docling
54,Offsetting of Certain Collateralized Transactions,[Assets]; Securities purchased under agreements to resell; Securities borrowed; [Liabilities]; Securities sold under agreements to repurchase; Securities loaned; Net amounts for which master netting agreements are not in place or may not be legally enforceable; Securities purchased under; Securities borrowed; Securities sold under,Assets; Liabilities,10q0325.pdf,27.096662030598054,docling
54,Offsetting of Certain Collateralized Transactions,Securities purchased under; Securities borrowed; Securities sold under; $ in millions; [Assets]; Securities purchased under agreements to resell; Securities borrowed; [Liabilities]; Securities sold under agreements to repurchase,Assets; Liabilities,10q0325.pdf,27.096662030598054,docling
54,Offsetting of Certain Collateralized Transactions,Securities borrowed; [Liabilities]; Securities sold under agreements to repurchase; Securities loaned; Net amounts for which master netting agreements are not in place or may not be legally enforceable; Securities purchased under; Securities borrowed; Securities sold under agreements to repurchase,Liabilities,10q0325.pdf,27.096662030598054,docling
54,Gross Secured Financing Balances by Remaining Contractual Maturity,$ in millions; Securities sold under agreements to repurchase; Securities loaned; **Total included in the offsetting disclosure**; Trading liabilities- Obligation to return securities received as collateral; **Total**,,10q0325.pdf,27.096662030598054,docling
54,Gross Secured Financing Balances by Remaining Contractual Maturity,$ in millions; Securities sold under agreements to repurchase; Securities loaned; **Total included in the offsetting disclosure**; Trading liabilities- Obligation to return securities received as collateral; **Total**,,10q0325.pdf,27.096662030598054,docling
54,Gross  Secured  Financing  Balances  by  Class  of  Collateral Pledged,Securities sold under agreements to repurchase; U.S. Treasury and agency securities; Other sovereign government obligations; Corporate equities; Other; **Total**; [Securities loaned]; Other sovereign government obligations; Corporate equities; Other,Securities loaned,10q0325.pdf,27.096662030598054,docling
54,Gross  Secured  Financing  Balances  by  Class  of  Collateral Pledged,Other sovereign government obligations; Corporate equities; Other; **Total**; **Total included in the offsetting disclosure**; Trading liabilities-Obligation to return securities received as collateral; Corporate equities; Other; **Total**; **Total**,,10q0325.pdf,27.096662030598054,docling
54,Gross  Secured  Financing  Balances  by  Class  of  Collateral Pledged,Other; **Total**; **Total**,,10q0325.pdf,27.096662030598054,docling
54,Carrying Value of Assets Loaned or Pledged without Counterparty Right to Sell or Repledge,Trading assets,,10q0325.pdf,27.096662030598054,docling
55,Fair Value  of Collateral Received  with  Right  to  Sell or Repledge,Collateral received with right to sell or repledge; Collateral that was sold or repledged,,10q0325.pdf,27.096662030598054,docling
55,Securities Segregated for Regulatory Purposes,Segregated securities,,10q0325.pdf,27.096662030598054,docling
55,Customer Margin and Other Lending,Margin and other lending,,10q0325.pdf,27.096662030598054,docling
55,Loans by Type,"$ in millions; Corporate; Secured lending facilities; Commercial real estate; Residential real estate; Securities-based lending and Other; **Total loans**; ACL; **Total loans, net**; Loans to non-U.S. borrowers, net",,10q0325.pdf,27.096662030598054,docling
55,Loans by Type,"$ in millions; Corporate; Secured lending facilities; Commercial real estate; Residential real estate; Securities-based lending and Other; **Total loans**; ACL; **Total loans, net**; Loans to non-U.S. borrowers, net",,10q0325.pdf,27.096662030598054,docling
55,Loans by Interest Rate Type,"$ in millions; Corporate; Secured lending facilities; Commercial real estate; Residential real estate; Securities-based lending and Other; **Total loans, before ACL**",,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; [2025]; 2024; 2023; 2022; 2021; Prior; **Total**,2025,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; 2025; 2024; 2023; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; 2025; 2024; 2023; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; 2025; 2024; 2023; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; 2024; 2023; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; 2025; 2024; 2023; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Loans Held for Investment before Allowance by Credit Quality and Origination Year,$ in millions; Revolving; 2024; 2023; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Past Due Loans Held for Investment before Allowance,Commercial real estate; Residential real estate; Securities-based lending and Other; **Total**,,10q0325.pdf,27.096662030598054,docling
56,Nonaccrual Loans Held for Investment before Allowance,Corporate; Secured lending facilities; Commercial real estate; Residential real estate; Securities-based lending and Other; **Total**; Nonaccrual loans without an ACL,,10q0325.pdf,27.096662030598054,docling
57,Period-end  loans  held  for  investment  modified  during  the  following periods,$ in millions; [Term Extension]; Corporate; Secured lending facilities; Commercial real estate; Securities-based lending and Other; **Total**; Other-than-insignificant Payment Delay; Securities-based lending and Other,Term Extension,10q0325.pdf,27.096662030598054,docling
57,Period-end  loans  held  for  investment  modified  during  the  following periods,**Total**; Other-than-insignificant Payment Delay; Securities-based lending and Other; **Total**; Multiple Modifications - Term Extension and Other-than-insignificant Payment Delay; Commercial real estate; **Total**; **Total Modifications**,,10q0325.pdf,27.096662030598054,docling
57,Financial Effect of Modifications on Loans Held for Investment,[Single Modifications]; Corporate; Secured lending facilities; Commercial real estate; Securities-based lending and Other,Single Modifications,10q0325.pdf,27.096662030598054,docling
57,Financial Effect of Modifications on Loans Held for Investment,[Single Modifications]; Corporate; Commercial real estate; Securities-based lending and Other; Multiple Modifications - Term Extension and Other-than-insignificant Payment Delay; Commercial real estate,Single Modifications,10q0325.pdf,27.096662030598054,docling
57,Past Due Loans Held for Investment Modified in the Last 12 months,$ in millions; Commercial real estate; $ in millions; Commercial real estate,,10q0325.pdf,27.096662030598054,docling
57,Allowance for Credit Losses Rollforward and AllocationLoans and Lending Commitments,$ in millions; [ACL-Loans]; Beginning balance; Gross charge-offs; Recoveries; Net (charge-offs)/ recoveries; Provision (release); Other; Ending balance; **Percent of loans to total loans**,ACL-Loans,10q0325.pdf,27.096662030598054,docling
57,Allowance for Credit Losses Rollforward and AllocationLoans and Lending Commitments,Other; Ending balance; **Percent of loans to total loans**; ACL-Lending commitments; Beginning balance; Provision (release); Other; Ending balance; **Total ending balance**,,10q0325.pdf,27.096662030598054,docling
58,Allowance for Credit Losses Rollforward and AllocationLoans and Lending Commitments,$ in millions; [ACL-Loans]; Beginning balance; Provision (release); Other; Ending balance; **Percent of loans to total loans**; ACL-Lending commitments; Beginning balance; Provision (release),ACL-Loans,10q0325.pdf,27.096662030598054,docling
58,Allowance for Credit Losses Rollforward and AllocationLoans and Lending Commitments,ACL-Lending commitments; Beginning balance; Provision (release); Other; Ending balance; **Total ending balance**,,10q0325.pdf,27.096662030598054,docling
58,Gross Charge-offs by Origination Year,$ in millions; 2022; 2021; Prior; **Total**,,10q0325.pdf,27.096662030598054,docling
58,Selected Credit Ratios,**ACL for loans to total HFI loans**; **Nonaccrual HFI loans to total HFI loans**; ACL for loans to nonaccrual HFI loans,,10q0325.pdf,27.096662030598054,docling
58,Employee Loans,"Currently employed by the Firm; No longer employed by the Firm; Employee loans; ACL; Employee loans, net of ACL; Remaining repayment term, weighted average in years",,10q0325.pdf,27.096662030598054,docling
58,Equity Method Investments,Investments; $ in millions; Income (loss),,10q0325.pdf,27.096662030598054,docling
59,Japanese Securities Joint Venture,$ in millions; Income (loss) from investment in MUMSS,,10q0325.pdf,27.096662030598054,docling
59,Tax Equity Investments under the Proportional Amortization Method,"Low-income housing; Renewable energy and other; **Total 1,2**",,10q0325.pdf,27.096662030598054,docling
59,Net Benefits Attributable to Tax Equity Investments under the Proportional Amortization Method,$ in millions; Income tax credits and other income tax benefits; Proportional amortization; Net benefits,,10q0325.pdf,27.096662030598054,docling
59,Deposits,Savings and demand deposits; Time deposits; **Total**; Deposits subject to FDIC insurance; Deposits not subject to FDIC insurance,,10q0325.pdf,27.096662030598054,docling
59,Time Deposit Maturities,2025; 2026; 2027; 2028; 2029; Thereafter; **Total**,,10q0325.pdf,27.096662030598054,docling
59,Borrowings,"Original maturities of one year or less; [Original maturities greater than one year]; Senior; Subordinated; **Total greater than one year**; **Total**; Weighted average stated maturity, in years",Original maturities greater than one year,10q0325.pdf,27.096662030598054,docling
59,Other Secured Financings,[Original maturities:];   One year or less;   Greater than one year; **Total**; Transfers of assets accounted for as secured financings,Original maturities:,10q0325.pdf,27.096662030598054,docling
60,Commitments,$ in millions; [Lending:];   Corporate;   Secured lending facilities;   Commercial and Residential real estate;   Securities-based lending and Other;   Forward-starting secured financing receivables;   Central counterparty;   Underwriting;   Investment activities,Lending:,10q0325.pdf,27.096662030598054,docling
60,Commitments,Central counterparty; Underwriting; Investment activities; Letters of credit and other financial guarantees; **Total**; Lending commitments participated to third parties,,10q0325.pdf,27.096662030598054,docling
60,Guarantees,"$ in millions; Non-credit derivatives; Standby letters of credit and other financial guarantees issued 2,3; Liquidity facilities; Whole loan sales guarantees; Securitization representations and warranties; General partner guarantees; Client clearing guarantees",,10q0325.pdf,27.096662030598054,docling
63,Consolidated VIE Assets and Liabilities by Type of Activity,$ in millions; MABS; Investment vehicles; MTOB; Other; **Total**,,10q0325.pdf,27.096662030598054,docling
64,Consolidated  VIE  Assets  and  Liabilities  by  Balance  Sheet Caption,[Assets]; Cash and cash equivalents; Trading assets at fair value; Investment securities; Customer and other receivables; Other assets; **Total**; [Liabilities]; Trading liabilities at fair value; Other secured financings,Assets; Liabilities,10q0325.pdf,27.096662030598054,docling
64,Consolidated  VIE  Assets  and  Liabilities  by  Balance  Sheet Caption,[Liabilities]; Trading liabilities at fair value; Other secured financings; Other liabilities and accrued expenses; Borrowings; **Total**; Noncontrolling interests,Liabilities,10q0325.pdf,27.096662030598054,docling
64,Non-consolidated VIEs,"$ in millions; VIE assets (UPB); [Maximum exposure to loss]; Debt and equity interests; Derivative and other contracts; Commitments, guarantees and other; **Total**; Carrying value of variable interests-Assets; Debt and equity interests; Derivative and other contracts",Maximum exposure to loss,10q0325.pdf,27.096662030598054,docling
64,Non-consolidated VIEs,Carrying value of variable interests-Assets; Debt and equity interests; Derivative and other contracts; **Total**; Additional VIE assets owned; Carrying value of variable interests-Liabilities; Derivative and other contracts; **Total**,,10q0325.pdf,27.096662030598054,docling
64,Non-consolidated VIEs,"$ in millions; VIE assets (UPB); [Maximum exposure to loss]; Debt and equity interests; Derivative and other contracts; Commitments, guarantees and other; **Total**; Carrying value of variable interests - Assets; Debt and equity interests; Derivative and other contracts",Maximum exposure to loss,10q0325.pdf,27.096662030598054,docling
64,Non-consolidated VIEs,Carrying value of variable interests - Assets; Debt and equity interests; Derivative and other contracts; **Total**; Additional VIE assets owned; Carrying value of variable interests-Liabilities; Derivative and other contracts,,10q0325.pdf,27.096662030598054,docling
65,Detail of Mortgage- and Asset-Backed Securitization Assets,$ in millions; Residential mortgages; Commercial mortgages; U.S. agency collateralized mortgage obligations; Other consumer or commercial loans; **Total**,,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,"$ in millions; SPE assets (UPB) 2,3; [Retained interests]; Investment grade; Non-investment grade; **Total**; Interests purchased in the secondary market; Investment grade; Non-investment grade; **Total**",Retained interests,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,Investment grade; Non-investment grade; **Total**; Derivative assets; Derivative liabilities,,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,"$ in millions; SPE assets (UPB) 2,3; [Retained interests]; Investment grade; Non-investment grade; **Total**; Interests purchased in the secondary market; Investment grade; Non-investment grade; **Total**",Retained interests,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,Investment grade; Non-investment grade; **Total**; Derivative assets; Derivative liabilities,,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,$ in millions; [Retained interests]; Investment grade; Non-investment grade; **Total**; Interests purchased in the secondary market; Investment grade; Non-investment grade; **Total**; Derivative assets,Retained interests,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,Non-investment grade; **Total**; Derivative assets; Derivative liabilities,,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,$ in millions; [Retained interests]; Investment grade; Non-investment grade; **Total**; Interests purchased in the secondary market; Investment grade; Non-investment grade; **Total**; Derivative assets,Retained interests,10q0325.pdf,27.096662030598054,docling
65,Transferred Assets with Continuing Involvement,Non-investment grade; **Total**; Derivative assets; Derivative liabilities,,10q0325.pdf,27.096662030598054,docling
65,Proceeds from New Securitization Transactions and Sales of Loans,$ in millions; New transactions; Retained interests,,10q0325.pdf,27.096662030598054,docling
66,Assets Sold with Retained Exposure,Gross cash proceeds from sale of assets; [Fair value]; Assets sold; Derivative assets recognized in the balance sheet; Derivative liabilities recognized in the balance sheet,Fair value,10q0325.pdf,27.096662030598054,docling
66,Capital Buffer Requirements,[Capital buffers]; Capital conservation buffer; SCB; G-SIB capital surcharge; CCyB; Capital buffer requirement,Capital buffers,10q0325.pdf,27.096662030598054,docling
66,Risk-Based Regulatory Capital Ratio Requirements,[Required ratios]; CET1 capital ratio; Tier 1 capital ratio; **Total capital ratio**,Required ratios,10q0325.pdf,27.096662030598054,docling
67,Risk-based capital,$ in millions; [Risk-based capital]; CET1 capital; Tier 1 capital; **Total capital**; **Total RWA**; [Risk-based capital ratio]; CET1 capital; Tier 1 capital; **Total capital**,Risk-based capital; Risk-based capital ratio,10q0325.pdf,27.096662030598054,docling
67,Risk-based capital,CET1 capital; Tier 1 capital; **Total capital**; [Required ratio]; CET1 capital; Tier 1 capital; **Total capital**,Required ratio,10q0325.pdf,27.096662030598054,docling
67,Leveraged-based capital,[Leveraged-based capital]; Adjusted average assets; Supplementary leverage exposure; [Leveraged-based capital ratio]; Tier 1 leverage; SLR; [Required ratio]; Tier 1 leverage; SLR,Leveraged-based capital; Leveraged-based capital ratio; Required ratio,10q0325.pdf,27.096662030598054,docling
67,MSBNA's Regulatory Capital,$ in millions; [Risk-based capital]; CET1 capital; Tier 1 capital; **Total capital**; Leverage-based; Tier 1 leverage; SLR,Risk-based capital,10q0325.pdf,27.096662030598054,docling
67,MSPBNA's Regulatory Capital,$ in millions; [Risk-based capital]; CET1 capital; Tier 1 capital; **Total capital**; [Leverage-based capital]; Tier 1 leverage; SLR,Risk-based capital; Leverage-based capital,10q0325.pdf,27.096662030598054,docling
67,MS&Co. Regulatory Capital,Net capital; Excess net capital,,10q0325.pdf,27.096662030598054,docling
68,Preferred Stock,"$ in millions, except per share data; [Series]; A; C; E; F; I; K; L; M",Series,10q0325.pdf,27.096662030598054,docling
68,Preferred Stock,K; L; M; N; O; P; Q; **Total**; Shares authorized,,10q0325.pdf,27.096662030598054,docling
68,Share Repurchases,$ in millions; Repurchases of common stock under the Firm's Share Repurchase Authorization,,10q0325.pdf,27.096662030598054,docling
68,Common Shares Outstanding for Basic and Diluted EPS,"in millions; Weighted average common shares outstanding, basic; Effect of dilutive RSUs and PSUs; Weighted average common shares outstanding and common stock equivalents, diluted; Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS)",,10q0325.pdf,27.096662030598054,docling
69,Dividends,"$ in millions, except per share data; [Preferred stock series]; A; C; E; F; I; K; L; M",Preferred stock series,10q0325.pdf,27.096662030598054,docling
69,Dividends,K; L; M; N; O; P; Q; **Total Preferred stock**; Common stock,,10q0325.pdf,27.096662030598054,docling
69,Accumulated Other Comprehensive Income (Loss),"December 31, 2024; OCI during the period; March 31, 2025; December 31, 2023; OCI during the period; March 31, 2024",,10q0325.pdf,27.096662030598054,docling
69,Components of Period Changes in OCI,$ in millions; [CTA]; OCI activity; [Reclassified to earnings]; Net OCI; Change in net unrealized gains (losses) on AFS securities; OCI activity; Reclassified to earnings; Net OCI; [Pension and other],CTA; Reclassified to earnings; Pension and other,10q0325.pdf,27.096662030598054,docling
69,Components of Period Changes in OCI,Reclassified to earnings; Net OCI; [Pension and other]; OCI activity; Reclassified to earnings; Net OCI; [Change in net DVA]; OCI activity; Reclassified to earnings; Net OCI,Pension and other; Change in net DVA,10q0325.pdf,27.096662030598054,docling
69,Components of Period Changes in OCI,OCI activity; Reclassified to earnings; Net OCI; Change in fair value of cash flow hedge derivatives; OCI activity; Reclassified to earnings; Net OCI,,10q0325.pdf,27.096662030598054,docling
69,Components of Period Changes in OCI,$ in millions; [CTA]; OCI activity; [Reclassified to earnings]; Net OCI; Change in net unrealized gains (losses) on AFS securities; OCI activity; Reclassified to earnings; Net OCI; [Pension and other],CTA; Reclassified to earnings; Pension and other,10q0325.pdf,27.096662030598054,docling
69,Components of Period Changes in OCI,Reclassified to earnings; Net OCI; [Pension and other]; OCI activity; Reclassified to earnings; Net OCI; [Change in net DVA]; OCI activity; Reclassified to earnings; Net OCI,Pension and other; Change in net DVA,10q0325.pdf,27.096662030598054,docling
69,Components of Period Changes in OCI,OCI activity; Reclassified to earnings; Net OCI; Change in fair value of cash flow hedge derivatives; OCI activity; Reclassified to earnings; Net OCI,,10q0325.pdf,27.096662030598054,docling
70,Interest Income and Interest Expense,"$ in millions; [Interest income]; Cash and cash equivalents; Investment securities; Loans; Securities purchased under agreements to resell; Securities borrowed; Trading assets, net of Trading liabilities; Customer receivables and Other; **Total interest income**",Interest income,10q0325.pdf,27.096662030598054,docling
70,Interest Income and Interest Expense,"Trading assets, net of Trading liabilities; Customer receivables and Other; **Total interest income**; [Interest expense]; Deposits; Borrowings; Securities sold under agreements to repurchase; Securities loaned; Customer payables and Other; **Total interest expense**",Interest expense,10q0325.pdf,27.096662030598054,docling
70,Interest Income and Interest Expense,Securities loaned; Customer payables and Other; **Total interest expense**; Net interest,,10q0325.pdf,27.096662030598054,docling
70,Accrued Interest,Customer and other receivables; Customer and other payables,,10q0325.pdf,27.096662030598054,docling
70,Selected Financial Information by Business Segment,"$ in millions; Investment banking; Trading; Investments; Commissions and fees; Asset management 1,2; Other; **Total non-interest revenues**; Interest income; Interest expense",,10q0325.pdf,27.096662030598054,docling
70,Selected Financial Information by Business Segment,**Total non-interest revenues**; Interest income; Interest expense; Net interest; Net revenues; Provision for credit losses; Compensation and benefits; Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes,,10q0325.pdf,27.096662030598054,docling
70,Selected Financial Information by Business Segment,Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes; Net income; Net income applicable to noncontrolling interests; Net income applicable to Morgan Stanley; Pre-tax margin,,10q0325.pdf,27.096662030598054,docling
70,Selected Financial Information by Business Segment,"$ in millions; Investment banking; Trading; Investments; Commissions and fees; Asset management 1,2; Other; **Total non-interest revenues**; Interest income; Interest expense",,10q0325.pdf,27.096662030598054,docling
70,Selected Financial Information by Business Segment,**Total non-interest revenues**; Interest income; Interest expense; Net interest; Net revenues; Provision for credit losses; Compensation and benefits; Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes,,10q0325.pdf,27.096662030598054,docling
70,Selected Financial Information by Business Segment,Non-compensation expenses; **Total non-interest expenses**; Income before provision for income taxes; Provision for income taxes; Net income; Net income applicable to noncontrolling interests; Net income applicable to Morgan Stanley; Pre-tax margin,,10q0325.pdf,27.096662030598054,docling
71,Detail of Investment Banking Revenues,$ in millions; Institutional Securities Advisory; Institutional Securities Underwriting; Firm Investment banking revenues from contracts with customers,,10q0325.pdf,27.096662030598054,docling
71,Trading Revenues by Product Type,$ in millions; Interest rate; Foreign exchange; Equity; Commodity and other; Credit; **Total**,,10q0325.pdf,27.096662030598054,docling
71,Investment Management Investments Revenues-Net Cumulative Unrealized Carried Interest,Net cumulative unrealized performance- based fees at risk of reversing,,10q0325.pdf,27.096662030598054,docling
71,Investment Management Asset  Management  RevenuesReduction of Fees Due to Fee Waivers,$ in millions; Fee waivers,,10q0325.pdf,27.096662030598054,docling
71,Other Expenses-Transaction Taxes,$ in millions; Transaction taxes,,10q0325.pdf,27.096662030598054,docling
71,Net Revenues by Region,$ in millions; Americas; EMEA; Asia; **Total**,,10q0325.pdf,27.096662030598054,docling
71,Revenues Recognized from Prior Services,$ in millions; Non-interest revenues,,10q0325.pdf,27.096662030598054,docling
72,Receivables from Contracts with Customers,Customer and other receivables,,10q0325.pdf,27.096662030598054,docling
72,Assets by Business Segment,Institutional Securities; Wealth Management; Investment Management; **Total**,,10q0325.pdf,27.096662030598054,docling
73,Average Balances and Interest Rates and Net Interest Income,$ in millions; Interest earning assets; Cash and cash equivalents:;   U.S.;   Non-U.S.;   Investment securities;   Loans;   Securities purchased under agreements to resell 2 :;   U.S.;   Non-U.S.,,10q0325.pdf,27.096662030598054,docling
73,Average Balances and Interest Rates and Net Interest Income,"Securities purchased under agreements to resell 2 :;   U.S.;   Non-U.S.;   Securities borrowed 3 :;   U.S.;   Non-U.S.;   Trading assets, net of Trading liabilities:;   U.S.;   Non-U.S.;   Customer receivables and Other:",,10q0325.pdf,27.096662030598054,docling
73,Average Balances and Interest Rates and Net Interest Income,"U.S.; Non-U.S.; Customer receivables and Other:;   U.S.;   Non-U.S.; **Total**; Interest bearing liabilities; Deposits; Borrowings 1,4; Securities sold under agreements to repurchase 5,7 :",,10q0325.pdf,27.096662030598054,docling
73,Average Balances and Interest Rates and Net Interest Income,"Deposits; Borrowings 1,4; Securities sold under agreements to repurchase 5,7 :;   U.S.;   Non-U.S.;   Securities loaned 6,7 :;   U.S.;   Non-U.S.;   Customer payables and Other 8 :;   U.S.",,10q0325.pdf,27.096662030598054,docling
73,Average Balances and Interest Rates and Net Interest Income,Non-U.S.; Customer payables and Other 8 :;   U.S.;   Non-U.S.; **Total**; Net interest income and net interest rate spread,,10q0325.pdf,27.096662030598054,docling
74,Glossary of Common Terms and Acronyms,ABS; ACL; AFS; AML; AOCI; AUM; Balance sheet; BHC; bps; Cash flow statement,,10q0325.pdf,27.096662030598054,docling
74,Glossary of Common Terms and Acronyms,BHC; bps; Cash flow statement; CCAR; CCyB; CDO; CDS; CECL; CET1; CFTC,,10q0325.pdf,27.096662030598054,docling
74,Glossary of Common Terms and Acronyms,CECL; CET1; CFTC; CLN; CLO; CMBS; CMO; CRE; CRM; CTA,,10q0325.pdf,27.096662030598054,docling
74,Glossary of Common Terms and Acronyms,CRE; CRM; CTA; DCP; DCP investments; DVA EBITDA; EMEA; FDIC,,10q0325.pdf,27.096662030598054,docling
74,Glossary of Common Terms and Acronyms,EMEA; FDIC; FFELP FHC; FICO; Financial statements; FVO; G-SIB; HFI; HFS,,10q0325.pdf,27.096662030598054,docling
74,Glossary of Common Terms and Acronyms,G-SIB; HFI; HFS; HQLA; HTM; I/E; IHC IM; Income statement,,10q0325.pdf,27.096662030598054,docling
75,Issuer Purchases of Equity Securities,"January; February; March; Three Months Ended March 31, 2025",,10q0325.pdf,27.096662030598054,docling
75,Exhibits,15; 31.1; 31.2; 32.1; 32.2; 101; 104,,10q0325.pdf,27.096662030598054,docling
75,Signatures,By:,,10q0325.pdf,27.096662030598054,docling
